论文部分内容阅读
The growing prevalence of type 2 diabetes highlights the limitations of available preventative options,and high rates of diabetes complications attest to the inadequacies of current treatments.Novel therapeutic strategies need to be informed by a more complete understanding of the molecular and physiological basis of disease,delivering validated interventional targets and biomarkers to define disease risk,progression,and subtype.